SEC CIK 1297709

Novartis Bioventures Ltd

Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ALTview stock →8,345,1452018-09-12
ARPOview stock →4,049,8042019-04-26
GRTXview stock →2,467,9612020-06-19
ALRNview stock →2,079,3942019-04-01
BCYCview stock →1,769,6412019-05-28
AKUSview stock →1,181,2582020-06-30

Position History — ARPO

Reported shares owned immediately after each Form 4 transaction, over time.

01,933,4173,866,8335,800,2502018-082019-032019-042019-042019-042019-042019-042019-04

Recent Filings — ARPO

DateActivitySharesPriceOwned After
2019-04-26Open-market sale138,704$1.034,049,804
2019-04-25Open-market sale563,096$1.034,188,508
2019-04-24Open-market sale16,403$1.034,751,604
2019-04-23Open-market sale27,554$1.034,768,007
2019-04-22Open-market sale7,100$0.974,795,561
2019-04-15Open-market sale28,794$0.994,802,661
2019-04-12Open-market sale30,908$1.044,831,455
2019-04-11Open-market sale57,438$1.084,862,363
2019-04-10Open-market sale140,230$1.094,919,801
2019-04-09Open-market sale32,991$1.015,060,031
2019-04-08Open-market sale27,525$1.025,093,022
2019-04-05Open-market sale24,661$1.025,120,547
2019-04-04Open-market sale47,900$1.015,145,208
2019-04-03Open-market sale58,033$0.965,193,108
2019-04-02Open-market sale51,754$0.975,251,141
2019-04-01Open-market sale116,909$0.955,302,895
2019-03-29Open-market sale63,100$0.915,419,804
2019-03-28Open-market sale88,835$0.945,482,904
2019-03-27Open-market sale50,749$0.995,571,739
2019-03-26Open-market sale177,762$1.015,622,488
2018-08-20Open-market sale5,300$3.905,800,250

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.